$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
Bemcentinib plus SOC including dabrafenib is well tolerated but does not improve efficacy in metastatic melanoma
2026-02-01 22:25:32
Check Details
Dabrafenib combined with tramatinib in the treatment of BRAF V600 mutated pediatric gliomas
2026-02-01 22:25:32
Check Details
ROAR Study Updates Dabrafenib/Trametinib Cure Benefits in BRAF V600E+ATC
2026-02-01 22:25:32
Check Details
Dabrafenib, tramatinib and Navitoclax combination shows promise for metastatic melanoma
2026-02-01 22:25:32
Check Details
What kind of medicine is Sofosbuvir and Velpatasvir?
2026-02-01 22:25:32
Check Details
What are the side effects of sofosbuvir and velpatasvir?
2026-02-01 22:25:32
Check Details
Sofosbuvir and velpatasvir usage and dosage
2026-02-01 22:25:32
Check Details
Can sofosbuvir and velpatasvir cure hepatitis C? What is the success rate?
2026-02-01 22:25:32
Check Details
When did sofosbuvir and velpatasvir come on the market?
2026-02-01 22:25:32
Check Details
How long does it take to take sofosbuvir and velpatasvir?
2026-02-01 22:25:32
Check Details
When is the best time of day to take Jisandai?
2026-02-01 22:25:32
Check Details
How do sofosbuvir and velpatasvir work? What is the mechanism of action?
2026-02-01 22:25:32
Check Details
1
2
...
373
374
375
376
377
378
379
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma